9th American Biotechnology Congress Aug 31 - Sep 2, 2015 Florida, USA ( 8:00 am )

9^th American Biotechnology Congress Aug 31 - Sep 2, 2015 Florida, USA

Omics Group invites the contributors across the globe to participate in the premier 9^th American biotechnology congress (Bio America-2015), to discuss the theme: "Biotechnology-emerging trends for a Sustainable Future". The conference will be held at the Florida, USA during August 31-september 02, 2015.

Url: http://www.biotechnologycongress.com/

9th American Biotechnology Congress Aug 31 - Sep 2, 2015 Florida, USA ( 8:00 am )

9^th American Biotechnology Congress Aug 31 - Sep 2, 2015 Florida, USA

Omics Group invites the contributors across the globe to participate in the premier 9^th American biotechnology congress (Bio America-2015), to discuss the theme: "Biotechnology-emerging trends for a Sustainable Future". The conference will be held at the Florida, USA during August 31-september 02, 2015.

Url: http://www.biotechnologycongress.com/

Professional Certification In Translational Medicine (PCTM) September 4, 2015 Vienna, Austria ( 8:00 am )

Professional Certification in Translational Medicine (PCTM) September 4, 2015 Vienna, Austria

Event location: Falkensteiner Hotel Wien Margareten Vienna, Austria
http://www.falkensteiner.com/en/hotel/margareten

Professional Certification in Translational Medicine (PCTM) program is designed by the Academy of Translational Medicine Professionals (ATMP) to set the standards for excellence in field of translational medicine and to promote and maintain high quality in clinical research

Program Accreditation
Professional Certification in Translational Medicine (PCTM) program is accredited by the European Society for Translational Medicine (EUSTM). After certification approval, successful individuals may use the title (PCTM). Certification is valid for two years from date of certification approval. Certification renewal application can be made after two years.

Certification Benefits
- Increased Job Opportunities
Professional certification will increase your job opportunities and accelerate your promotions by highlighting you from other colleagues and pool of other candidates.

- Stay-Up-To-Date
Professional certification will ensure translational medicine knowledge and skills are up to date.

- Show Your Competency
Professional certification will show your competency to conduct and manage translational research studies.

- Demonstrate Your Commitment
Professional certification demonstrates your commitment to the advancement of clinical research.

PCTM Preparatory Course
To prepare for the PCTM qualifying examination, preparatory course would be held on 4th September, 2015 in Vienna, Austria.

PCTM Qualifying Examination
In order to receive PCTM title, applicants must pass the qualifying exam (MCQs type) held on 4th September, 2015 (one hour duration).

Registration Fees
- PCTM Preparatory Course: 400 €
- PCTM Qualifying Examination: 150 €

Contact Info : Academy of Translational Medicine Professionals (ATMP) European Society for Translational Medicine (EUSTM) Schönbrunner Straße 293/10/12, 1120, Vienna, Austria. E-Mail: Website: www.eutranslationalmedicine.org/pctm Phone: +43 1 8923 562 Fax: +43 1 8923 562 Url: http://www.eutranslationalmedicine.org/pctm

Cell & Gene Therapy Conference September 9-10, 2015 In Philadelphia, PA, USA ( 9:00 am )

Cell & Gene Therapy Conference September 9-10, 2015 in Philadelphia, PA, USA

We invite you to attend the 2nd Cell & Gene Therapy Conference, which will take place September 9-10, 2015 in Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues and gain fresh perspective on the various research.

Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges and pre-clinical requirements, emerging technologies, the development and applications of cell and gene therapy, as well as business models and commercial milestones.
 

Session Topics:
I. Emerging Technologies
II. Pre-clinical Research
III. Clinical Development
IV. Strategies for Commercialization
V. Regulatory Challenges
VI. Funding/Finance for Cell & Gene Therapy

Url: https://www.gtcbio.com/conferences/cell-gene-therapy-overview

Cell & Gene Therapy Conference September 9-10, 2015 In Philadelphia, PA, USA ( 9:00 am )

Cell & Gene Therapy Conference September 9-10, 2015 in Philadelphia, PA, USA

We invite you to attend the 2nd Cell & Gene Therapy Conference, which will take place September 9-10, 2015 in Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues and gain fresh perspective on the various research.

Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges and pre-clinical requirements, emerging technologies, the development and applications of cell and gene therapy, as well as business models and commercial milestones.
 

Session Topics:
I. Emerging Technologies
II. Pre-clinical Research
III. Clinical Development
IV. Strategies for Commercialization
V. Regulatory Challenges
VI. Funding/Finance for Cell & Gene Therapy

Url: https://www.gtcbio.com/conferences/cell-gene-therapy-overview

FMC 2015 - Frontiers In Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015 ( 8:00 am )

FMC 2015 - Frontiers in Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015

The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).

Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV, Belgium), the Société Royale de Chimie (SRC, Belgium), and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV, The Netherlands).

This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. It attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for Frontiers 2015 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

Url: http://www.frontiers2015.org

FMC 2015 - Frontiers In Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015 ( 8:00 am )

FMC 2015 - Frontiers in Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015

The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).

Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV, Belgium), the Société Royale de Chimie (SRC, Belgium), and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV, The Netherlands).

This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. It attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for Frontiers 2015 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

Url: http://www.frontiers2015.org

FMC 2015 - Frontiers In Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015 ( 8:00 am )

FMC 2015 - Frontiers in Medicinal Chemistry Antwerp, Belgium - September 14-16, 2015

The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry).

Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV, Belgium), the Société Royale de Chimie (SRC, Belgium), and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV, The Netherlands).

This biennial meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. It attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for Frontiers 2015 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

Url: http://www.frontiers2015.org

Cancer Vaccines 16th – 17th September 2015 Marriott Regents Park, London ( 9:00 am )

Cancer Vaccines 16th – 17th September 2015 Marriott Regents Park, London

Cancer Vaccines helps to boost the immune system's recognition and resistance to cancer cells. Thus, increased knowledge of our immune system has opened up new combination therapies in immuno-oncology, to enhance immune response, as some the latest treatments incorporate monoclonal antibodies and genetically engineered viral vectors to kill tumours.

Some of the hottest topics will include:
• CAR T-Cell Therapy
• Oncolytic viral therapies
• Gene-therapy
• Adoptive T-Cell transfer

In addition, two- panel discussions on both days will bring some key questions to light including the commercial vial ability of personalised treatments.

However, it has also become clear that cancer cells have different ways of eluding the immune system, which makes creating effective vaccines difficult.

Researchers are also studying the best way to give vaccines, looking to see if they work better when used alone or with other types of cancer treatments. Therefore key discussion points in our 2-day interactive panel will include:

• Development of combination treatments - which ones are best?
• Driving the next generation tools in cancer immunotherapy
• How will technology and data systems need to change in order to allow personalised treatment to evolve?

Cancer Vaccines 16th – 17th September 2015 Marriott Regents Park, London ( 9:00 am )

Cancer Vaccines 16th – 17th September 2015 Marriott Regents Park, London

Cancer Vaccines helps to boost the immune system's recognition and resistance to cancer cells. Thus, increased knowledge of our immune system has opened up new combination therapies in immuno-oncology, to enhance immune response, as some the latest treatments incorporate monoclonal antibodies and genetically engineered viral vectors to kill tumours.

Some of the hottest topics will include:
• CAR T-Cell Therapy
• Oncolytic viral therapies
• Gene-therapy
• Adoptive T-Cell transfer

In addition, two- panel discussions on both days will bring some key questions to light including the commercial vial ability of personalised treatments.

However, it has also become clear that cancer cells have different ways of eluding the immune system, which makes creating effective vaccines difficult.

Researchers are also studying the best way to give vaccines, looking to see if they work better when used alone or with other types of cancer treatments. Therefore key discussion points in our 2-day interactive panel will include:

• Development of combination treatments - which ones are best?
• Driving the next generation tools in cancer immunotherapy
• How will technology and data systems need to change in order to allow personalised treatment to evolve?

Nucleic Acid Summit Sept 17-18, 2015 San Francisco, CA ( 8:00 am )

Nucleic Acid Summit Sept 17-18, 2015 San Francisco, CA

• 6th Non-Coding RNA and RNAi Research & Therapeutics
• Analytic PCRs
• Microarray Analysis

Url: https://www.gtcbio.com/conferences

Nucleic Acid Summit Sept 17-18, 2015 San Francisco, CA ( 8:00 am )

Nucleic Acid Summit Sept 17-18, 2015 San Francisco, CA

• 6th Non-Coding RNA and RNAi Research & Therapeutics
• Analytic PCRs
• Microarray Analysis

Url: https://www.gtcbio.com/conferences

6th Biobased Chemicals: Commercialization & Partnering Sept 18-19, 2015 San Francisco, CA ( 8:00 am )

6th Biobased Chemicals: Commercialization & Partnering Sept 18-19, 2015 San Francisco, CA

Url: https://www.gtcbio.com/conferences

6th Biobased Chemicals: Commercialization & Partnering Sept 18-19, 2015 San Francisco, CA ( 8:00 am )

6th Biobased Chemicals: Commercialization & Partnering Sept 18-19, 2015 San Francisco, CA

Url: https://www.gtcbio.com/conferences

CNS Diseases World Summit Sept 22-23, 2015 Boston, MA ( 8:00 am )

CNS Diseases World Summit Sept 22-23, 2015 Boston, MA

Url: https://www.gtcbio.com/conferences

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA ( 8:00 am )

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA

• Fragment Based Drug Discovery Sept 22-23
• Histone Acetyltransferases and Deacetylases Inhibitors Design & Screening Sept 22-23
• Molecular Modeling in Drug Discovery Sept 24-25
• Protein Kinase Inhibitors Design & Screening Sept 24-25

Url: https://www.gtcbio.com/conferences

CNS Diseases World Summit Sept 22-23, 2015 Boston, MA ( 8:00 am )

CNS Diseases World Summit Sept 22-23, 2015 Boston, MA

Url: https://www.gtcbio.com/conferences

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA ( 8:00 am )

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA

• Fragment Based Drug Discovery Sept 22-23
• Histone Acetyltransferases and Deacetylases Inhibitors Design & Screening Sept 22-23
• Molecular Modeling in Drug Discovery Sept 24-25
• Protein Kinase Inhibitors Design & Screening Sept 24-25

Url: https://www.gtcbio.com/conferences

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA ( 8:00 am )

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA

• Fragment Based Drug Discovery Sept 22-23
• Histone Acetyltransferases and Deacetylases Inhibitors Design & Screening Sept 22-23
• Molecular Modeling in Drug Discovery Sept 24-25
• Protein Kinase Inhibitors Design & Screening Sept 24-25

Url: https://www.gtcbio.com/conferences

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA ( 8:00 am )

Drug Discovery & Medicinal Chemistry Summit Sept 22-25, 2015 Boston, MA

• Fragment Based Drug Discovery Sept 22-23
• Histone Acetyltransferases and Deacetylases Inhibitors Design & Screening Sept 22-23
• Molecular Modeling in Drug Discovery Sept 24-25
• Protein Kinase Inhibitors Design & Screening Sept 24-25

Url: https://www.gtcbio.com/conferences

11th EFMC Short Course On Medicinal Chemistry Engineering Of Biopharmaceuticals ( 9:00 am )

11th EFMC Short Course on Medicinal ChemistryEngineering of BiopharmaceuticalsOegstgeest (near Leiden), The Netherlands - September 27-30, 2015

This intensive course is intended for scientists with interests in the field of peptide and protein engineering covering topics around synthetic peptides, engineered proteins and therapeutic antibodies.

The number of participants will be limited to 35 to assure the possibility for in-depth discussions. The presentations and tutorials will be given by academic and industrial experts and will cover broad historical perspectives and in depth details of important engineering technologies. The presenters will also include interesting applications as well as future aspects in an informal approach aiming for high level of interaction of the participants.

Course outline

Course Organiser
Jesper LAU (Novo Nordisk, Denmark)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.675 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course.

 

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

11th EFMC Short Course On Medicinal Chemistry Engineering Of Biopharmaceuticals ( 9:00 am )

11th EFMC Short Course on Medicinal ChemistryEngineering of BiopharmaceuticalsOegstgeest (near Leiden), The Netherlands - September 27-30, 2015

This intensive course is intended for scientists with interests in the field of peptide and protein engineering covering topics around synthetic peptides, engineered proteins and therapeutic antibodies.

The number of participants will be limited to 35 to assure the possibility for in-depth discussions. The presentations and tutorials will be given by academic and industrial experts and will cover broad historical perspectives and in depth details of important engineering technologies. The presenters will also include interesting applications as well as future aspects in an informal approach aiming for high level of interaction of the participants.

Course outline

Course Organiser
Jesper LAU (Novo Nordisk, Denmark)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.675 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course.

 

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

11th EFMC Short Course On Medicinal Chemistry Engineering Of Biopharmaceuticals ( 9:00 am )

11th EFMC Short Course on Medicinal ChemistryEngineering of BiopharmaceuticalsOegstgeest (near Leiden), The Netherlands - September 27-30, 2015

This intensive course is intended for scientists with interests in the field of peptide and protein engineering covering topics around synthetic peptides, engineered proteins and therapeutic antibodies.

The number of participants will be limited to 35 to assure the possibility for in-depth discussions. The presentations and tutorials will be given by academic and industrial experts and will cover broad historical perspectives and in depth details of important engineering technologies. The presenters will also include interesting applications as well as future aspects in an informal approach aiming for high level of interaction of the participants.

Course outline

Course Organiser
Jesper LAU (Novo Nordisk, Denmark)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.675 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course.

 

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

11th EFMC Short Course On Medicinal Chemistry Engineering Of Biopharmaceuticals ( 9:00 am )

11th EFMC Short Course on Medicinal ChemistryEngineering of BiopharmaceuticalsOegstgeest (near Leiden), The Netherlands - September 27-30, 2015

This intensive course is intended for scientists with interests in the field of peptide and protein engineering covering topics around synthetic peptides, engineered proteins and therapeutic antibodies.

The number of participants will be limited to 35 to assure the possibility for in-depth discussions. The presentations and tutorials will be given by academic and industrial experts and will cover broad historical perspectives and in depth details of important engineering technologies. The presenters will also include interesting applications as well as future aspects in an informal approach aiming for high level of interaction of the participants.

Course outline

Course Organiser
Jesper LAU (Novo Nordisk, Denmark)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.675 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course.

 

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

Biosimilars And Biobetters 30th September – 1st October 2015 Holiday Inn Kensington Forum, London ( 9:00 am )

Biosimilars and Biobetters 30th September – 1st October 2015 Holiday Inn Kensington Forum, London

The development of the Biosimilars market is growing exponentially with the industry forecast to be worth $25 billion by 2020. With the regulatory landscape evolving rapidly, it is important to understand the developments in the biosimilar guideline framework and the cohesion in legislation between Europe and the US.

With Europe leading the way in the field of Biosimilar development, it is important to get to grips with all areas in the product lifecycle from early stage developments, protein characterisation and analytical comparability to patent litigation, market access, pricing and reimbursement through to emerging markets and global developments. Every angle should be considered and taken account for through the development process and with the EU the most advanced market for biosimilars, accounting for 80% of global spending on these molecules, the learning curve for biosimilars is essentially still building and there are hurdles to overcome.

Unlocking the potential of biosimilars will require a focused strategy along the whole value chain, from optimizing the clinical development program through developing the most suitable strategy for commercialisation.

Url: https://www.smi-online.co.uk/pharmaceuticals/uk/conference/biosimilars-and-biobetters